Lipoic acid - Biological activity and therapeutic potential

Pharmacological Reports

Volumn 63, Issue 4, 2011, Pages 849-858

  Gora̧ca, Anna ^a   Huk Kolega, Halina ^a   Piechota, Aleksandra ^a   Kleniewska, Paulina ^a   Ciejka, Elzbieta ^b   Skibska, Beata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Health Care School of Bialystok   (Poland)

Author keywords

Antioxidant activity; Lipoic acid; Therapeutic application

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DIHYDROLIPOATE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHOTREXATE; PLACEBO; THIOCTIC ACID; TUBERCULOSTATIC AGENT;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CHELATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG IDENTIFICATION; DRUG INDICATION; DRUG INFORMATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; FATTY LIVER; FOOD COMPOSITION; HUMAN; LIVER FIBROSIS; LIVER PROTECTION; LIVER TOXICITY; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; NEUROPATHY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RESPIRATORY CHAIN; REVIEW; SINGLE DRUG DOSE; TREATMENT RESPONSE;

EID: 80053351784     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70600-4     Document Type: Review

References (88)

1. Al-Attar AM: Physiological and histopatological investigations on the effects of α-lipoic acid in rats exposed to malathion. J Biomed Biotechnol, 2010, 2010: 203503, doi:101155/2010/203503.
2. Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G: Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res, 2004, 94, 1211-1218. (Pubitemid 38656407)
3. Arivazhagan P, Ramanathan K, Panneerselvam C: Effect of DL-α-lipoic acid on mitochondrial enzymes in aged rats. Chem Biol Interact, 2001, 138, 189-198. (Pubitemid 32973851)
4. Arivazhagan P, Panneerselvam SR, Panneerselvam C: Effect of DL-α-lipoic acid on the status of lipid peroxidation and lipids in aged rats. J Gerontol A Biol Sci Med Sci, 2003, 58, B788-B791.
5. Baldwin AS Jr: NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol, 1996, 14, 649-681.
6. Bast A, Haenen GR: Lipoic acid: a multifunctional antioxidant. Biofactors, 2003, 17, 207-213. (Pubitemid 37267155)
7. Beckman MA, Creager P, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc, 2002, 287, 2570-2581.
8. Bickford PC, Gould T, Briederick L, Chadman K, Pollock A, Young D, Shukitt-Hale B et al.: Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res, 2000, 866, 211-217. (Pubitemid 30313023)
9. Biewenga G, Haenen G, Bast A: The pharmacology of the antioxidant lipoic acid. Gen Pharmacol, 1997, 29, 315-331.
10. Bilska A, Dudek M, Iciek M, Kwiecień I, Sokołowska-Jezewicz M, Filipek B, Włodek L: Biological action of lipoic acid associated with sulfane metabolism. Pharmacol Rep, 2007, 60, 225-232.
11. Bilska A, Włodek L: Lipoic acid-the drug of the future. Pharmacol Rep, 2005, 57, 570-577.
12. Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F: Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with α-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism. Life Sci, 2010, 86, 844-853.
13. Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H, Wahl P,: α-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med, 1999, 26, 1495-1500. (Pubitemid 29302282)
14. Breithaupt-Grögler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS: Dose-proportionality of oral thioctic acid-coincidence of assessments via pooled and individual data. Eur J Pharmacol Sci, 1999, 8, 57-65. (Pubitemid 29117269)
15. Bush AJ: Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging, 2002, 23, 1031-1038.
16. Çakatay U, Kayali R, Sivas A, Tekeli F: Prooxidant activities of R-α-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch Gerontol Geriat, 2005, 40, 231-240. (Pubitemid 40462245)
17. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A et al.: Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci, 2005, 233, 145-162. (Pubitemid 40812334)
18. Carreau JP: Biosynthesis of lipoic acid via unsaturated fatty acids. Meth Enzymol, 1979, 62, 152-158.
19. Christie LA, Studzinski CM, Araujo JA, Leung CS, Ikeda-Douglas CJ, Head E, Cotman CW, Milgram NW: A comparison of egocentric and allocentric age-dependent spatial learning in the beagle dogs. Prog Neuropsychpharmacol Biol Psychiatry, 2005, 29, 361-369. (Pubitemid 40417587)
20. Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y, Pimentel D et al.: S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol, 2006, 26, 2454-2461. (Pubitemid 44607465)
21. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA: Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 2001, 50, 1927-1937. (Pubitemid 33641615)
22. Cremer DR, Rabeler R, Roberts A, Lynch B.: Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol, 2006, 46, 29-41. (Pubitemid 44293048)
23. Cremer DR, Rabeler R, Roberts A, Lynch B: Long-term safety of α-lipoic acid (ALA) consumption: A 2-years study. Regul Toxicol Pharmacol, 2006, 46, 193-201. (Pubitemid 44692904)
24. De Marco VG, Bosanquet JP, Rawlani VR, Skimming JW: Lipoic acid decreases exhaled nitric oxide concentrations in anesthetized endotoxemic rats. Vasc Pharmacol, 2005, 43, 4040-10.
25. Di Lisa F, Nina Kaludercic N, Carpi A, Menabò R, Giorgio M: Mitochondria and vascular pathology. Pharmacol Rep, 2009, 61, 123-130.
26. Doraiswamy PM, Finefrock AE: Metals in our minds: therapeutic implications for neurodegenerative disorders. Lance Neurol, 2004, 3, 431-434. (Pubitemid 38789138)
27. Eason RC, Archer HE, Akhtar S, Bailey CJ: Lipoic acid increases glucose uptake by skeletal muscles of obese-diabetic ob/ob mice. Diabetes Obes Metab, 2002, 4, 29-35. (Pubitemid 34285264)
28. Ghibu S, Richard C, Vergely C, Zeller M, Cottin Y, Rochette L: Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J Cardiovasc Pharmacol, 2009, 54, 391-398.
29. Gleiter CH, Schug BS, Hermann R, Elze M, Blume HH, Gundert-Remy U: Influence of food intake on the bioavailability of thioctic acid enantiomers (letter). Eur J Clin Pharmacol, 1996, 50, 513-514. (Pubitemid 26281074)
30. Gora̧ca A, Asłanowicz-Antkowiak K: Prophylaxis with alpha-lipoic acid against lipopolisaccharide-induced brain injury in rats. Arch Immunol Ther Exp (Warsz), 2009, 57, 141-146.
31. Gora̧ca A, Piechota A, Huk-Kolega H: Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart. J Physiol Pharmacol, 2009, 60, 61-68.
32. Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC et al.: R-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J, 1999, 13, 411-418. (Pubitemid 29072418)
33. Head E, Nukala VN, Fenoglio KA, Muggenburg BA, Cotman CW, Sullivan PG: Effects of age, dietary and behavioral enrichment on brain mitochondria in a canine model of human aging. Exp Neurol, 2009, 220, 171-176.
34. Heinisch BB, Francesconi M, Mittermayer F, Schaller G, Gouya G, Wolzt M, Pleiner: Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial, Eur J Clin Invest, 2010, 40, 148-154.
35. Hermann R, Niebch G, Borbe H.O, Fieger-Büschges H, Ruus P, Nowak H, Riethmüller-Winzen H et al.: Enantioselective pharmacokinetics and bioavailability of different racemic alpha-lipoic acid formulations in healthy volunteers. Eur J Clin Pharmacol Sci, 1996, 4, 167-174. (Pubitemid 26174670)
36. Hofmann MA, Schiekofer S, Kanitz M, Klevesath MS, Joswig M, Lee V, Morcos M: Insufficient glycemic control increases nuclear factor kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care, 1998, 21, 1310-1316. (Pubitemid 28365689)
37. Holmquist L, Stuchbury G, Berbaun K: Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther, 2007, 113, 154-164. (Pubitemid 44969927)
38. Hui AY, Friedman SL: Molecular basis of hepatic fibrosis. Expert Rev Mol Med, 2003, 5, 1-23.
39. Janson M: Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging. Clin Interv Aging, 2006, 13, 261-265.
40. Kataoka H: Chromatographic analysis of lipoic acid and related compounds. J Chromatogr B, 1998, 717, 247-262.
41. Kayali R, Cakatay U, Akcay T, Altug T: Effect of alphalipoic acid supplementation on markers of protein oxidation in post-mitotic tissues of ageing rat. Cell Biochem Funct, 2006, 24, 79-85. (Pubitemid 43171011)
42. Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Kim GS, Kim HH: Antioxidant α-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-κB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-κB ligand and tumor necrosis factor-α. Free Radic Biol Med, 2006, 40, 1483-1493.
43. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY: α-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity. Exp Mol Med, 2007, 39, 106-113.
44. Kim HY, Or Y, Kim M, Yokozawa T: Protective effect of lipoic acid against methylglyoxal-induced oxidative stress in LLC-PK1 cells. J Nutr Sci Vitaminol, 2008, 54, 99-104. (Pubitemid 351413110)
45. Kozlov AV, Gille L, Staniek K, Nohl H: Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Arch Biochem Biophys, 1999, 363, 148-154. (Pubitemid 29394341)
46. Lachman J, Hamouz K, Orsak M, Pivec V: Potato tubers as a significant source of antioxidants in human nutrition. Rostlinna Vyroba, 2000, 46, 231-236.
47. Lee HS, Na MH, Kim WK: α-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer line. Nutr Res, 2010, 30, 403-409.
48. 2+by dihydrolipoic acid prevents human low density lipoprotein per oxidation. Free Radic Biol Med, 1998, 25, 287-297.
49. Marangon K, Devaraj S, Tirosh O, Packer L, Jialal I: Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med, 1999, 27, 1114-1121. (Pubitemid 29507484)
50. Mc Carthy MF, Barroso-Aranda J, Contreras F: The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-γ coactivator-1α. Med Hypotheses, 2009, 72, 29-33.
51. Miadokova E, Vlckova V, Duhova V: Antimutagenic effect of alpha-lipoic acid on three model test systems. Pharmazie, 2000, 55, 862-863.
52. Mijnhout GS, Alkhalaf A, Kleefstra N, Bilo HJ: Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes? Neth J Med, 2010, 68, 158-162.
53. Min AK, Kim MK, Seo HY, Kim HS, Jang BK, Hwang JS, Choi HS, Lee KU et al.: Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-β signaling pathway. Biochem Biophys Res Commun, 2010, 393, 536-541.
54. Na MH, Seo EY, Kim WK: Effects of α-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells. Nutr Res Pract, 2009, 3, 265-271.
55. Novotny L, Rauko P, Cojocel C: α-Lipoic acid - the potential for use in cancer therapy. Neoplasma, 2008, 55, 81-86.
56. Ou P, Tritschler HJ, Wolf SP: Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol, 1995, 50, 123-126.
57. Pack RA, Hardy K, Madigan MC, Hunt NH: Differential effects of the antioxidant α-lipoic acid on the proliferation of mitogen-stimulated peripheral blood lymphocytes and leukaemic T cells. Mol Immunol, 2002, 38, 733-745. (Pubitemid 34158876)
58. Packer L: α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drug Metab Rev, 1998, 30, 245-275.
59. Packer L, Kraemer K, Rimbach G: Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 2001, 17, 888-895. (Pubitemid 33001657)
60. Packer L, Witt EH, Tritschler HJ: α-Lipoic acid as a biological antioxidant. Free Radic Biol Med, 1995, 19, 227-250.
61. Park KG, Min AK, Koh EH, Kim HS, Kim MO, Park HS, Kim YD et al.: Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology, 2008, 48, 1477-1486.
62. Reed LJ, DeBusk BG, Gansalus IC, Hornberger Jr CS: Crystalline α-lipoic acid: a catalytic agent associated with pyruvate dehydrogenase. Ciences, 1951, 114, 93-94.
63. Roudebush P, Zicker SC, Cotman CW, Milgram NW, Muggenburg BA, Head E: Nutritional management of brain aging in dogs. J Am Vet Med Assoc, 2005, 227, 722-728. (Pubitemid 41266281)
64. Saad EI, El-Gowilly SM, Sherhaa MO, Bistawroos AE: Role of oxidative stress and nitric oxide in the protective effects of α-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats. Food Chem Toxicol, 2010, 48, 1869-1875.
65. Schupke H, Hempel R, Peter G, Hermann R, Wessel K, Engel J, Kronbach T: New metabolic pathways of α-lipoic acid. Drug Metab Dispos, 2001, 29, 855-862. (Pubitemid 32488642)
66. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM: Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim Biophys Acta, 2009, 1790, 1149-1160.
67. Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, Nair KS: Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA, 2005, 102, 5618-5623. (Pubitemid 40530306)
68. Singh U, Jialal I: Alpha-lipoic acid supplementation and diabetes. Nutr Rev, 2008, 66, 646-657.
69. Skibska B, Józefowicz-Okonkwo G, Gora̧ca A: Protective effects of early administration of alpha-lipoic acid against lipopolysaccharide-induced plasma lipid peroxidation. Pharmacol Rep, 2006, 58, 399-404. (Pubitemid 44111075)
70. Stoll S, Hartmann H, Cohen SA, Muller WE: The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDAreceptor deficits. Pharmacol Biochem Behav, 1993, 46, 799-805.
71. Studzinski CM, Christie LA, Araujo JA, Burnham WM, Head E, Cotman CW, Milgram NW: Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia. Neurobiol Learn Mem, 2006, 86, 197-204. (Pubitemid 44287579)
72. Suh JH, Moreau R, Health SH, Hagen TM: Dietary supplementation with (R)- α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep, 2005, 10, 52-60. (Pubitemid 41556830)
73. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM: Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA, 2004, 101, 3381-3386. (Pubitemid 38338203)
74. Suzuki YJ, Tsachya M, Packer L: Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun, 1991, 15, 255-263.
75. Suzuki YJ, Aggarwal BB, Packer L: Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun, 1992, 189, 1709-1715. (Pubitemid 23041360)
76. Svegliati-Baroni G, Saccomanno S, van Goor P, Jansen P, Benedett A, Moshage H: Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver, 2001, 21, 1-12. (Pubitemid 32112013)
77. Tabassum H, Parvez S, Pasha ST, Banerjee BD, Raisuddin S: Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol, 2010, 48, 1973-1979.
78. Tapp PD, Siwak CT, Estrada J, Muggenburg BA, Head E, Cotman CW, Milgram NW: Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. Learn Mem, 2003, 10, 64-73. (Pubitemid 36177022)
79. Teichert J, Preiss R: HPLC-methods for determination of lipoic acid and its reduced form in human. Int J Clin Pharmacol Ther Toxicol, 1992, 30, 511-512. (Pubitemid 23001962)
80. Valko M, Morris H, Cronin MT: Metals, toxicity and oxidative stress. Curr Med Chem, 2005, 12, 1161-1208. (Pubitemid 40655271)
81. van de Mark K, Chen JS, Steliou K, Perrine SP, Faller DV: Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. J Cell Physiol, 2003, 194, 325-340. (Pubitemid 36181524)
82. Vig-Varga E, Benson EA, Limbil TL, Allison BM, Goebl MG, Harrington MA: Alpha-lipoic acid modulates ovarian surface epithelial cell growth. Gynecol Oncol, 2006, 103, 45-52. (Pubitemid 44374679)
83. Wenzel U, Nickel A, Daniel H: α-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-• generation. Apoptosis, 2005, 10, 359-368. (Pubitemid 40603489)
84. Yan LJ, Traber MG, Kobuchi H, Matsugo S, Tritscher HJ, Packer L: Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch Biochem Biophys, 1996, 327, 330-334. (Pubitemid 26086586)
85. Ying Z, Kherada N, Farrar B, Kampfrath T, Chung Y, Simonetti O, Deiuliis J et al.: Lipoic acid effects on established atherosclerosis. Life Sci, 2010, 86, 95-102.
86. Zhang WJ, Frei B: α-Lipoic acid inhibits TNF-α-induced NF κB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J, 2001, 15, 2423-2432.
87. Zhu X, Su B, Wang X, Smith MA, Perry G: Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci, 2007, 64, 2202-2210. (Pubitemid 47347959)
88. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerun G et al.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a 7-month multicenter randomized controled trial (ALADIN III study). Diabetes Care, 1999, 22, 1296-1301. (Pubitemid 29350240)